Drug Receptor Interactions Flashcards

1
Q

What are receptors ? Also briefly describe their role.

A

Receptors are specialised, localised proteins whose role it is to recognise stimulants and translate this event into an activation of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the main general properties of interaction between the drug and receptor

A
  • Loose
  • Freely reversible
  • Does not involve strong chemical bonds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Identify the regulatory protein families which are commonly drug targets and are covered by the term receptor:

A
  1. Enzymes
  2. Carrier molecules (transporters)
  3. Ion channels
  4. Neurotransmitter, hormone or local hormone receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Is the active site of a receptor specific for one drug only ?

A

No, may fit more than one chemical substance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How similar are agonists and antagonists, chemically ?

A

a) Both bind same receptor, so must be chemical similarities

b) One activates the receptor, other does not: Must also be chemical differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the law of mass action ?

A

“The rate of a chemical reaction is proportional to the product of the concentration of the reactants”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do forward and backward rates compare at equilibrium ?

A

They are equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to the forward and backward rate of a reaction at equilibrium if more reactant is added ?

A

Forward rate will increase (i.e. be more than the backward rate) until a new eq is reached

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When the law of mass of action is applied to pharmacology, what does the following stand for ?
(D) + (R) ⇌ (DR) ⇌ (DR)*
K1 and K2
α and β

What does the first part of the equation stand for ?
What does the second part stand for ?

A

[D] is the concentration of drug
[R] is the concentration of receptors
[DR] is the concentration of occupied receptors
K1 is the rate constant for associations
K2 is the rate constant for dissociations
α is the rate constant of receptor inactivation
β is the rate constant of receptor activation

First part is occupancy
Second part is activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the formula for rate of associations ?

for rate of dissociations

A

rate of associations: (K1.[D].[R])

rate of dissociations: (K2.[DR])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is affinity in the context of pharmacology ?

A

(KD or KA) is a measure of the concentration range over which a drug binds to its receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How may we experimentally determine the affinity of a receptor for a drug ?

A
  1. Label the drug
  2. Incubate the drug at various concentrations, with the receptor
  3. Allow dynamic equilibrium to be established
  4. Filtrate bound receptor-drug complex from unbound drugs
  5. Must take non-specific binding into account (binding in areas other than active site): add unlabelled drug, which will therefore bind to active site. Only signal coming from labeled drugs is from the ones non-specifically bound (gives measure of non-specific binding)
  6. Subtract non-specific binding from total binding to obtain specific binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the shape of the graph obtained when graphing Quantity of Specifically Bound Drug vs Concentration ?

A

Hyperbolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What information does the log scale graph of specifically bound drug vs concentration (log scale) give you ?

A

Maximum Binding

Affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the equilibrium dissociation constant ?

A

KD, concentration of drug required to occupy 50% of the receptors at equilibrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is the KD the same for all drugs ?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Can you measure affinity for a mixed population of drugs and/or receptors ? Why or why not ?

A

No, because KD is a measure of the affinity of any one drug for a receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is fractional occupancy ?

A

The fraction of all receptors that are bound to ligand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the formula for fractional occupancy ?

A

Fractional Occupancy = [DR]/totalR = DR/[R]+[DR]

Given the unknowns we have, including the concentration of unoccupied receptor (so cannot determine [DR], so use HILL LANGMUIR equation:

Fractional occupancy = [D] / ([D] + KD)
where,
[D] is the concentration of drug
KD is the equilibrium dissociation constant of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In the theoretical relationship between occupancy and ligand concentration, what would be the shape of the graph using:

  • a linear concentration scale
  • a log concentration scale
A
  • a linear concentration scale: rectangular hyperbola

- a log concentration scale: symmetrical sigmoid curve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

At which value of fractional occupancy is KD found ?

A

At 50% (because KD is the concentration of drug required to occupy 50% of the receptors at equilibrium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is pD2 ? What is its usage ?

A

pD2 = -log10(KD)
Conventional to express the equilibrium dissociation constant (KD) as -log10 of the KD. This is called the pD2 for an agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Will affinity be larger for an agonist with a higher or lower pD2 ?

A

Higher (because -log10 of a small number is larger than -log10 of a larger number)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is efficacy ?

A

Ability of the drug to generate/initiate a stimulus once bound to its receptor

25
Q

Why is efficacy not the same as affinity ?

A

Because the maximum response of a tissue can be obtained by occupying less than 100% of the receptors

26
Q

What kind of a relationship is there between drug concentration and the magnitude of the response obtained ?

A

Systematic relationship

27
Q

What is the main conclusion of the occupancy theory ?

A

Response α fraction of receptors occupied –> Response = % of receptors occupied –> Response = [DR]/[RT]

28
Q

What is the actual formula for response ?

A
Response = f(Stimulus)
Stimulus = [DR]/[RT]
Response = f([DR]/[RT])
29
Q

If < 100% of receptors are required to evoke a maximum response, what are these “extra” receptors called ?

A

SPARE RECEPTORS

30
Q

What is the difference between an efficacious drug and a less efficacious one ?

A

A very efficacious drugs will require to occupy fewer receptors to give a response than less efficacious ones

31
Q

What is the function of a partial agonist ?

A

↓ the response to a full agonist because some receptors will be occupied by partial agonist molecules, giving a smaller response than if all the receptors were occupied by full agonist molecules

32
Q

What is a competitive antagonist ?

A

Drug which interacts/binds reversibly with receptors to form a complex but this complex does not evoke a response

33
Q
[D] + [R] + [A]  = ? 
Where 
[D] is the drug
[R]  is a receptor
[A] is a competitive antagonist
A

[D] + [R] + [A] = [DR] + [AR]
Where
Only [DR] give rise to a response
[AR] are receptors which are occupied but not activated

34
Q

What is the measure of affinity of the antagonist to the receptor ?

A

Ka = Equilibrium dissociation constant for an antagonist

35
Q

What is the effect of a competitive antagonist on Log Dose-response curve ?

A
  • Displaced to the right
  • Maximum response to agonist remains the same
  • “Linear” sections are parallel
36
Q

What is the Schild equation ? What does it show ?

A

r = ([A]/KA) + 1

Calculates the ratio by which the drug must be increased to overcome competition by the competitive antagonist.

37
Q

What is the Equilibrium dissociation constant for an antagonist (Ka) (in normal words) ?

A

Concentration of antagonist that makes it necessary to add twice as much agonist to produce a response as would be needed in the absence of the antagonist

38
Q

What is the pA2 of a drug ?

A

Measure of affinity of competitive antagonist for a specific receptor.

39
Q

What is the formula for pA2 ?

A

pA2 = -log10(KA)

40
Q

Can partial agonists ever produce a 100% response ? A full agonist ?

A

No

Yes

41
Q

How do orthosteric/allosteric inhibitors work ?

A

Antagonist blocks access of the agonist to its binding site through steric hindrance.
Alter conformation of receptor, making it difficult to bind to active site

42
Q

How do orthosteric/allosteric inhibitors work ?

A

Antagonist blocks access of the agonist to its binding site through steric hindrance.
Bind to binding site and alter conformation of active site on the receptor, making it difficult to bind to active site

43
Q

What are the main groups of osthosteric/allosteric inhibitors ?

A

Non competitive inhibitors

44
Q

What is an allosteric site ? Can they modify the affinity ? efficacy ?

A
  • Regulatory site, not ‘active’ binding sites

- Can modify the affinity or efficacy of a receptor’s endogenous ligand or drug (may either potentiate or inhibit)

45
Q

How does a Irreversible Competitive Antagonist affect the Log Dose-response curves ?

A

Slope decreased

Maximum response to agonist decreased

46
Q

How do non competitive inhibitors work ?

A

Antagonist binds to a site that is independent of the active site.

47
Q

Do non competitive inhibitors affect efficacy and/or affinity ?

A

They can affect either efficacy or affinity (if affect efficacy, also affect affinity. May also affect just affinity)

48
Q

How do non competitive inhibitors affect Log Dose-response curves ?

A

Negative affinity modulation: Push it to the right but same maximum response
Negative efficacy modulation: Decreased maximum response

49
Q

Do irreversible competitive inhibitors affect efficacy and/or affinity ?

A

They affect efficacy AND affinity at once ???

50
Q

Do reversible competitive inhibitors affect efficacy and/or affinity ?

A

They affect affinity only

51
Q

What is the premise behind homeopathy ?

A

Dilution and potency of homoeopathic medicines is inversely proportional

52
Q

What is the difference between Ka and Kd ?

A
Ka = Equilibrium dissociation constant for an antagonist
Kd = Equilibrium dissociation constant, concentration of drug required to occupy 50% of the receptors at equilibrium

Ka is for antagonist, Kd is for the drug

53
Q

What are some formulas which involve Ka, and Kd respectively ?

A
pA2 = -log10(KA)
pD2 = -log10(KD)
54
Q

How is a full agonist going to change the shape of a Log Dose-response curve for occupancy (both the full and partial agonists being included) ?

A

Full agonist: Increased affinity, increased efficacy

Partial agonist: Decreased affinity, decreased effiacy

55
Q

What is the mechanism of action of inverse agonists ?

A

Binds with the constitutively active receptors at the active site, stabilize them and shifts receptor equilibrium towards the inactive state, reducing the level of basal activity ie: negative efficacy or negative intrinsic activity.

56
Q

Why are inverse agonists not simply considered antagonists ?

A

Because it can evoke a response (unlike antagonists) even if response is to reduce level of receptor activation

57
Q

What happens if you add an inverse agonist to a system with just an agonist (no antagonist) ?

A

Get dampening of the response

58
Q

What happens if you add a competitive antagonist in the presence of an inverse agonist, according to a Log Dose-response curve ?

A

A shift to the right of the curve

59
Q

Can the Schild equation (calculating r = Ratio by which [D] must be increased to overcome competition by [A]) be used for inverse agonists ?

A

Absolutely yes